Perfuze raised €22M in a funding round in Mar 2025. The company is based in Newcastle, Ireland. Investors in the round: Earlybird, EQT Life Sciences, Seroba and 1 other. Data as of 21 Sept 2026.
Reported in EUR — no conversion. €22M
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
